{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:29:11Z","timestamp":1782361751941,"version":"3.54.5"},"reference-count":31,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T00:00:00Z","timestamp":1146182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Aventis"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The treatment of lung cancer has reached a therapeutic plateau. Several mechanisms of platinum resistance have been described, including the removal of platinum\u2010DNA adduct by nucleotide excision repair (NER). Polymorphisms within the Xeroderma pigmentosum Group D protein (XPD), a member of the NER pathway, are associated with alterations in enzyme activity and may change sensitivity to platinum\u2010based chemotherapy. The authors investigated the relation between XPD polymorphisms and treatment response, toxicity, and overall survival in patients who received platinum\u2010based chemotherapy for advanced nonsmall cell lung cancer (NSCLC).<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Between 2001 and 2002, 108 patients with chemotherapy\u2010naive, advanced NSCLC were recruited. Associations between XPD312\/751 polymorphisms and XPD haplotype and treatment response, toxicity. and survival were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Significant correlations were observed between XPD haplotype and Grade 4 neutropenia and overall survival together with a greater response to platinum\u2010based chemotherapy for the XPD *A haplotype.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The XPD haplotype may represent a useful pharmacogenomic marker of platinum\u2010based chemotherapy in patients with advanced NSCLC and requires prospective validation. Cancer 2006. \u00a9 2006 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.21885","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T18:21:31Z","timestamp":1146248491000},"page":"2421-2427","source":"Crossref","is-referenced-by-count":41,"title":["Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum\u2010based chemotherapy in advanced nonsmall cell lung cancer"],"prefix":"10.1002","volume":"106","author":[{"given":"Richard","family":"Booton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Heighway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-2-37"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3210"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.02.068"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011954"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1229"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601487"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(02)00047-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00141-5"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00142-7"},{"key":"e_1_2_5_11_2","first-page":"4899","article-title":"Transcription\u2010coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"Furuta T","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.3.349"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.21.6559"},{"key":"e_1_2_5_14_2","first-page":"8654","article-title":"A Xeroderma pigmentosum Group D gene polymorphism predicts clinical outcome to platinum\u2010based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park DJ","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_5_15_2","first-page":"22","article-title":"Transcription coupled repair, XPD and RRM1 gene polymorphisms predict gemcitabine\/cisplatin outcome in NSCLC","author":"Taron M","year":"2003","journal-title":"Proc Am Soc Clin Oncol."},{"key":"e_1_2_5_16_2","first-page":"877","article-title":"XPD polymorphisms in cisplatin\/vinorelbine treated Stage IV NSCLC patients: genetic analysis of a Spanish Lung Cancer Group Phase II trial","volume":"22","author":"Reguart N","year":"2003","journal-title":"Proc Am Soc Clin Oncol."},{"key":"e_1_2_5_17_2","first-page":"859","article-title":"Single nucleotide polymorphisms in DNA repair genes predicts survival in gemcitabine\/cisplatin treated NSCLC patients","volume":"22","author":"Sarries C","year":"2003","journal-title":"Proc Am Soc Clin Oncol."},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.03.016"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.6.1710"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"key":"e_1_2_5_21_2","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz MR","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.14.2745"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.8.3.195"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.8.3.175"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03412.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/35057149"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/35103535"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genom.2.1.235"},{"key":"e_1_2_5_29_2","first-page":"21","article-title":"XPD polymorphism is associated with clinical outcome in advanced colorectal cancer patients treated with 5\u2010FU\/oxaliplatin chemotherapy","author":"Park DJ","year":"2002","journal-title":"Proc Am Soc Clin Oncol."},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601975"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.067"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2003.11.019"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.21885","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.21885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T18:11:22Z","timestamp":1760292682000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.21885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,18]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1002\/cncr.21885"],"URL":"https:\/\/doi.org\/10.1002\/cncr.21885","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,18]]}}}